Skip to main content
. 2018 Feb 22;23(5):556–565. doi: 10.1634/theoncologist.2017-0535

Table 2. Key clinical trials of PAM50 and PAM50‐ROR.

image

Abbreviations: CI, confidence interval; DRFS, disease‐recurrence‐free survival; ER, estrogen receptor; HER2, human epidermal growth receptor 2; HR, hazard ratio; LumA, luminal A; LumB, luminal B; OS, overall survival; PAM50, 50‐gene Prediction Analysis of Microarrays; pCR, pathological complete response; PEPI‐0 status, preoperative endocrine prognostic index 0 status; PFS, progression‐free survival; PR, progesterone receptor; ROR, Risk of Recurrence; RS, Recurrence Score.